Medication info
Biel Memantine Tablets 10mg (Memantine Hydrochloride)

Biel Memantine Tablets 10mg (Memantine Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Memantine Hydrochloride›10mg / 1 tablet
Manufacturer / importer
LightPharmTech Co., Ltd.
Appearance
White oblong film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201902775 · Approved 2019.04.30 · Insurance code 690300930

Summary

Main use
Treatment of moderate to severe Alzheimer's disease
Who takes it
Adults
Adult dose
Administer this medicine orally once daily, at the same time each day. If necessary, this medicine may be administered twice daily. This medicine may be taken with or without food. 1. Adults Dose titration: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows to reach the maintenance dose. Week 1 (days 1-7) Administer 5mg daily for 7 days. Week 2 (days 8-14) Administer 10mg daily for 7 days. Week 3 (days 15-21) Administer 15mg daily for 7 days. From week 4 onward Administer 20mg daily. Maintenance dose: The recommended maintenance dose is 20mg daily. 2. Older adults: Based on clinical data, the recommended dose for older patients 65 years of age and older is 20mg daily. 3. Patients with renal impairment: No dose adjustment is required in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-49 mL/min), the daily dose should be reduced to 10mg. If well tolerated after at least 7 days of treatment, the dose may be increased to 20mg daily according to the standard dose-titration schedule. In patients with severe renal impairment (creatinine clearance 5-29 mL/min), the daily dose should be reduced to 10mg. 4. Patients with hepatic impairment: No dose adjustment is required in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine.

Ingredients

Manufacturer
LightPharmTech Co., Ltd.

Efficacy & effects

Treatment of moderate to severe Alzheimer's disease

  • Alzheimer's disease
View approved original text

This medication is used for the treatment of moderate to severe Alzheimer's disease.

How to take

Adult dose

Administer this medicine orally once daily, at the same time each day. If necessary, this medicine may be administered twice daily. This medicine may be taken with or without food. 1. Adults Dose titration: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows to reach the maintenance dose. Week 1 (days 1-7) Administer 5mg daily for 7 days. Week 2 (days 8-14) Administer 10mg daily for 7 days. Week 3 (days 15-21) Administer 15mg daily for 7 days. From week 4 onward Administer 20mg daily. Maintenance dose: The recommended maintenance dose is 20mg daily. 2. Older adults: Based on clinical data, the recommended dose for older patients 65 years of age and older is 20mg daily. 3. Patients with renal impairment: No dose adjustment is required in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-49 mL/min), the daily dose should be reduced to 10mg. If well tolerated after at least 7 days of treatment, the dose may be increased to 20mg daily according to the standard dose-titration schedule. In patients with severe renal impairment (creatinine clearance 5-29 mL/min), the daily dose should be reduced to 10mg. 4. Patients with hepatic impairment: No dose adjustment is required in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine.

Precautions

This medication should not be used in patients who are allergic to any of its ingredients. It should not be administered to patients with severely impaired liver function or significantly reduced kidney function. Patients with epilepsy or a history of seizures, or those predisposed to epilepsy, should use this medication with caution. Combining this medication with certain drugs such as Amantadine, Ketamine, or Dextromethorphan may increase the risk of side effects, so it is advisable not to take them together. Changes in diet or certain urinary tract infections that alter the acidity of urine can affect the efficacy or side effects of this medication, so careful monitoring is needed. Patients with heart disease or uncontrolled hypertension should exercise caution when using this medication, as there is insufficient clinical data. Common side effects may include dizziness, headache, constipation, drowsiness, and hypertension, which are mostly mild or moderate in severity. Psychological confusion, hallucinations, or psychotic symptoms may rarely occur; if such symptoms emerge, patients should consult their doctor. This medication may interact with other drugs, so it is essential to inform the doctor if taking any other medications. Women who are pregnant or may become pregnant should use this medication cautiously after consulting their doctor, as it may affect the fetus. If breastfeeding, it is safest to discontinue nursing, as this medication may pass into breast milk. The safety and efficacy of this medication have not been established in children or adolescents under the age of 18. In case of overdose, central nervous system symptoms or gastrointestinal symptoms may arise, and immediate medical attention should be sought. This medication may affect the patient's reaction speed, requiring caution when driving or operating machinery. Store out of reach of children and ensure that it is not transferred to another container.

Side effects

  • Dizziness
  • headache
  • constipation
  • drowsiness
  • hypertension
  • fungal infection
  • drug hypersensitivity reaction
  • confusion
  • hallucinations
  • psychotic reactions
Show 23 more
  • balance disorders
  • gait abnormalities
  • seizures
  • heart failure
  • venous thromboembolism/thrombosis
  • shortness of breath
  • vomiting
  • pancreatitis
  • elevated liver function test values
  • hepatitis
  • fatigue
  • tiredness
  • weakness
  • diarrhea
  • agitation
  • aggression
  • delirium
  • unconsciousness
  • restlessness
  • psychosis
  • visual hallucinations
  • double vision
  • coma

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture, and it is best kept at room temperature between 1°C and 30°C. Storing it this way helps maintain the medication's efficacy over time.

Appearance and packaging

Appearance

White oblong film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.